Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

L Dugas; C Dubray; J P Herry; Niels Vidiendal Olsen; M Court-Payen; J M Hansen; P Robach; A Ter-Minassian; J P Richalet

Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

L Dugas, C Dubray, J P Herry, Niels Vidiendal Olsen, M Court-Payen, J M Hansen, P Robach, A Ter-Minassian, J P Richalet

Eyepath Lab

6 Citationer (Scopus)

Abstract

High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

Bidragets oversatte titel	Cardiovascular effects of a calcium channel blocker in hypoxia caused by altitude
Originalsprog	Fransk
Tidsskrift	Presse Medicale
Vol/bind	24
Udgave nummer	16
Sider (fra-til)	763-8
Antal sider	6
ISSN	0755-4982
Status	Udgivet - 29 apr. 1995

Emneord

Adult
Altitude Sickness
Anoxia
Capillary Permeability
Cardiovascular Diseases
Color Perception
Double-Blind Method
Female
Hemodynamics
Humans
Isradipine
Kidney Function Tests
Male
Middle Aged
Placebos

Citationsformater

@article{b55ed75f6f624f3b8a7ce81fda309ab4,

title = "Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude",

abstract = "High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.",

keywords = "Adult, Altitude Sickness, Anoxia, Capillary Permeability, Cardiovascular Diseases, Color Perception, Double-Blind Method, Female, Hemodynamics, Humans, Isradipine, Kidney Function Tests, Male, Middle Aged, Placebos",

author = "L Dugas and C Dubray and Herry, {J P} and Olsen, {Niels Vidiendal} and M Court-Payen and Hansen, {J M} and P Robach and A Ter-Minassian and Richalet, {J P}",

year = "1995",

month = apr,

day = "29",

language = "Fransk",

volume = "24",

pages = "763--8",

journal = "Presse Medicale",

issn = "0755-4982",

publisher = "Elsevier Masson",

number = "16",

}

TY - JOUR

T1 - Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

AU - Dugas, L

AU - Dubray, C

AU - Herry, J P

AU - Olsen, Niels Vidiendal

AU - Court-Payen, M

AU - Hansen, J M

AU - Robach, P

AU - Ter-Minassian, A

AU - Richalet, J P

PY - 1995/4/29

Y1 - 1995/4/29

N2 - High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

AB - High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

KW - Adult

KW - Altitude Sickness

KW - Anoxia

KW - Capillary Permeability

KW - Cardiovascular Diseases

KW - Color Perception

KW - Double-Blind Method

KW - Female

KW - Hemodynamics

KW - Humans

KW - Isradipine

KW - Kidney Function Tests

KW - Male

KW - Middle Aged

KW - Placebos

M3 - Tidsskriftartikel

C2 - 7784415

SN - 0755-4982

VL - 24

SP - 763

EP - 768

JO - Presse Medicale

JF - Presse Medicale

IS - 16

ER -

Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

Abstract

Emneord

Fingeraftryk

Citationsformater